been some major updates to their prospects.
Timeline is now approx 7 months before an expected FDA decision.
Share price is at $5 and change
JPMorgan just came out and upgraded the target price to $19 which is $5/sh higher than mine. But mine is also conservative cause there are some unknowns with regard to sales and revenues and reimbursements and...
and there is a post on the CRMD board by someone named EASYRIDER.. close to 50 recs, and the recs are well deserved for what he sums up.. and I agree with all of it.
Anyways, maybe CRMD finally gets to move forward. And if we are correct, $14/19 will be the first step..